Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy
Clinical trial NCT06414577 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06414577
- Sponsor
- XIANG YANQUN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-22
- Primary completion
- 2025-03-23
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.